Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

SBEV US Equity

Splash Beverage Group, Inc.Consumer Staples · Beverages · CIK 1553788 · FY ends Dec 31
$0.47
+0.05 (+10.94%)
USD · as of 2026-08-21 · marketstack

SBEV · 10-K · period ended 2025-12-31

← all SBEV documents
filed 2026-04-15 · EDGAR original ↗

Our rendering of the filing — original pagination and typography are not reproduced, and tables are reduced to their short label cells (the figures live on FA). Nothing is summarized: every line below is the filing's own text.

blocks 1600 of 2,436210k characters rendered

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2025

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________to _________

Commission File Number 001-40471

SPLASH BEVERAGE GROUP, INC.

(Exact name of registrant as specified in its charter)

1314 E Las Olas Blvd. Suite 221

Fort Lauderdale, FL33301

(Address of principal executive offices) (Zip code)

(954)745-5815

(Registrant’s telephone number, including

area code)

Not Applicable

(Former name, former address and former fiscal year,

if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol Name of each exchange on which registered

Common Stock, $0.001 par value per share SBEV NYSE American LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known

seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes

☒No

Indicate by check mark if the registrant is not required

to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐

Yes ☒No

Indicate by check mark whether the registrant (i)

has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months

(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements

for the past 90 days. ☒Yes☐

No

Indicate by checkmark whether the registrant has submitted

electronically every Interactive Data File required to be submitted pursuant to rule 405 of Regulation S-T during the preceding 12 months

(or for such shorter period that the registrant was required to submit such files). ☒Yes☐ No

Indicate by checkmark whether the registrant is a

large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See

the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and

“emerging growth company,” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐

Non-accelerated filer ☒ Smaller reporting company ☒

Emerging growth company ☐

If an emerging growth company, indicate by check mark

if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards

provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has

filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting

under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its

audit report. ☐

If securities are registered pursuant to Section

12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the

correction of an error to previously issued financial statements. ☒

Indicate by check mark whether any of those error

corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s

executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a

shell company (as defined in rule 12b-2 of the Act). ☐ Yes ☒No

The aggregate market value of the Registrant’s

common equity held by non-affiliates computed by reference to the price at which the common equity was last sold as of the last business

day of the Registrant’s most recently completed second quarter was $6,454,754.

On April 14, 2026, there were 9,953,538 shares of

Common Stock issued and outstanding.

Documents

Incorporated by Reference

Portions

of the registrant’s definitive proxy statement for its 2026 Annual Meeting of Stockholders are incorporated by reference in Items

10, 11, 12, 13, and 14 of Part III of this Annual Report on Form 10-K.

SPLASH BEVERAGE GROUP, INC.

FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2025

TABLE OF CONTENTS

Page

PART I 1

Item 1. Business 1

Item 1A. Risk Factors 5

Item 1B Unresolved Staff Comments 23

Item 1C Cybersecurity 23

Item 2. Properties 23

Item 3. Legal Proceedings 23

Item 4. Mine Safety Disclosures 24

Item 6. Selected Financial Data 25

Item 7A. Quantitative and Qualitative Disclosures about Market Risk 30

Item 8. Financial Statements and Supplementary Data F-1

Item 9A. Controls and Procedures 31

Item 9B. Other Information 32

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 33

PART III 34

Item 10. Directors, Executive Officers and Corporate Governance

Item 11. Executive Compensation

Item 14. Principal Accounting Fees and Services

Item 15. Exhibits and Financial Statement Schedules 35

Signatures 41

i

PART I

Except as otherwise indicated, references to “we”,

“us”, “our”, “Splash” and the “Company” refer to Splash Beverage Group,

Inc. and its wholly owned subsidiaries.

This Annual Report on Form

10-K (this “Annual Report” or this “Report”) contains “forward-looking statements” Forward-looking

statements reflect our current view about future events. When used in this Report, the words “anticipate,” “believe,”

“estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these

terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements include, but

are not limited to, statements contained in this Report relating to our business strategy, our future operating results and liquidity

and capital resources outlook. Forward-looking statements are based on our current expectations and assumptions regarding our business,

the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties,

risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by

the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution

you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ

materially from those in the forward-looking statements include, without limitation our need for additional capital to resume our revenue-generating

operations, our ability to raise the capital needed on favorable terms or at all, our ability to meet regulatory requirements including

the rules of the New York Stock Exchange (the “NYSE”) and maintain the listing of our Common Stock on the NYSE American, our

ability to meet our debt obligations and the negative financial and operational consequences of failing to do so, our ability to close

our planned acquisition of a CBD business, and the risks and uncertainties disclosed in “Item 1A -Risk Factors” contained

in this Report. Actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.

Factors or events that could

cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee

future results, levels of activity, performance or achievements. We undertake no obligation to publicly update any forward-looking statement,

whether as a result of new information, future developments or otherwise, except as may be required by law.

Item 1. Business.

Company Overview

Historically, Splash was a portfolio company seeking

to manage brands across viable growth segments within the consumer beverage industry. As a result of our lack of capital, we did not generate

revenue from February 2025 until March 2026 when we delivered tequila as described below. Our beverage operations have historically not

been profitable. Because of our lack of capital to generate revenue, our management reviewed strategic alternatives inside and outside

of the beverage industry. As a result, on March 4, 2026 the Company entered into a non-binding letter of intent setting forth the principal

terms of a potential acquisition of a leading manufacturer and multi-brand operator of federally compliant cannabinoid wellness products.

See “Letter of Intent” immediately below for more information. As of the date of this Report, the Company has not entered

into a definitive written agreement with respect to such potential transaction. The delay has been caused by a quest to make the acquisition

tax-free for the target’s equity holders. Because the process for doing so would delay the closing of the proposed acquisition until

late 2026, the Company has agreed to pay additional cash to the target company’s investors to cover their income taxes and reduce

the equity component of the acquisition.

1

Letter

of Intent

On March 4, 2026, Splash entered into a letter of intent (the

“Letter”) with the target company, Medterra CBD, LLC (“Medterra”), a leading manufacturer and multi-brand operator

of federally compliant cannabinoid wellness products. Pursuant to the Letter, the parties agreed in principal on the terms of a potential

business combination between Medterra and the Company, which transaction is subject to due diligence and execution of a definitive written

agreement and other applicable agreements, receipt of audited financial statements of Medterra and customary closing conditions. In addition,

the Company shall be required to raise capital to pay off Medterra’s debt of approximately $10.4 million. The proposed terms for

the acquisition reflect an enterprise value of Medterra of $37.6 million or the issuance of approximately 54.4 million shares of Common

Stock, which assumes repayment of its outstanding debt and delivery of approximately $10,000,000 in cash to pay off and extinguish the

debt of Medterra and to cover the income taxes of the Medterra equity holders. At closing the Company will issue Medterra investors a

number of shares of the Company’s Common Stock equal to up to 19.99% of the Company’s Common Stock then outstanding, and the

remaining shares will be of two series of convertible preferred stock (“Series X” and “Series X-1”) to be issued

to Medterra’s equity holders based on their existing ownership interests in Medterra. The Series X and X-1 shares will convert at

$0.50 per share. The Common Stock to be issued at the closing shall have full rights equal to all outstanding Common Stock, except the

holders may not vote upon the stockholder approval of the change of control contemplated by the acquisition. The Letter also provides

that the Company will issue Series X-1 to Medterra’s lender with the stated value based upon the equity value of Medterra. In exchange

the lender shall cancel its warrants to purchase equity of Medterra.

The Company

now expects it can close the acquisition of Medterra in May 2026. The closing will be subject to the Company’s planned meetings

with investors during the week of April 13th and its ability to raise the necessary capital as well as reaching a definitive

agreement with Medterra and the parties meeting the closing conditions.

Because the Company recently rescinded its June 2025 acquisition of certain water

rights in Costa Rica, it derecognized the $20 million of stockholders’ equity which created a stockholders’ deficit of $15,300,828

at December 31, 2025. The NYSE American Rules required us to have at least $6 million in stockholders’ equity. With the expected

stockholder’s equity created by the Medterra acquisition, the Company will be in compliance with the NYSE American Rules. The Company

is seeking to meet with the NYSE American Staff as soon as possible. There is no assurance that the NYSE American will permit us to maintain

the listing of our Common Stock. See Item 1A – “Risk Factors.”

Our Strategy

Our primary focus is to complete the acquisition of

Medterra as described above under “Letter of Intent.”

In addition, we are focusing on re-commencing material revenue-generating

operations through our beverage business, including through sales of our Chispo Tequila brand subject to obtaining sufficient capital.

In the furtherance of this Chispo tequila opportunity, in December 2025 we purchased $50,000 of inventory for the potential Senior Frogs

order described under “Chispo Tequila” below.

The

Company did not make any sales in the 2025 calendar year after March 2025 due to its lack of capital resources. The

Company estimates that it will initially require $3,000,000 for the Chispo brand as well as general and administrative expenses

for the next 12 months.

Chispo Tequila

Chispo is a tequila brand

which we recently began distributing to one customer. See “Senor Frogs Selection” below. Chispo is an authentic

blue agave blanco tequila, with fresh, sweet citrus, herbal floral notes ideal for cocktail mixing. We have entered into an arrangement

with the Chispo producer under which we agreed to distribute the brand in certain states in the U.S., as well as in Guatemala and Europe.

We expect that we will need approximately $500,000 in new financing to implement this business.

2

Senior Frogs Selection

In January 2026 the Company announced that Senor Frog’s, an internationally

recognized restaurant and entertainment brand known for its vibrant atmosphere and authentic cuisine, selected Chispo Tequila as its house

tequila across an initial group of locations in Florida, the Bahamas, and Mexico. Senor Frog’s belongs to Grupo Anderson’s

Mexico who owns more than 50 business units and 15 distinct restaurant brands across 4 countries. In March 2026, we shipped initial inventory

to a distributor which we expect will permit us to recognize revenue for the three months ended March 31, 2026.

The rollout marks Chispo’s first high-profile

national hospitality partner, providing early validation of the brand’s positioning and quality as it begins to scale in the on-premise

channel. Senor Frog’s selected Chispo following an extensive evaluation of authentic tequila brands, with a focus on taste profile,

consistency, and resonance with its broad and diverse customer base. Chispo’s smooth character and approachable style distinguished

it in a competitive field of premium and value-positioned tequilas. Chispo Tequila is produced in Jalisco, Mexico in partnership with

ZB Distillery, a respected distilling operation known for its commitment to quality and traditional tequila craftsmanship.

Costa Rica Water

On June 25, 2025, the Company entered into an Asset

Purchase Agreement (the “Asset Purchase Agreement”) with a third party (the “Seller”) under which the Seller

sold certain water assets located in Costa Rica to the Company in exchange for $20 million of Series C Convertible Preferred Stock

(the “Series C”). The Company issued the Series C to the Seller. Section 1.04 of the Asset Purchase Agreement required the

Seller to deliver the water assets by December 31, 2025 or pay the Company $20 million in cash. Section 1.04 of the Asset Purchase

Agreement further stated that failure to deliver either the water assets or the $20 million by December 31, 2025 rendered the Series

C to be “null, void, and of no further force or effect.” The Seller failed to comply with either requirement. As a result,

on April 14, 2026, the Board of Directors of the Company terminated the Asset Purchase Agreement and cancelled the Series C effective

December 31, 2025.

3

Competition

We compete with a large variety of other companies

in the marketplace for the sale of alcoholic products. The beverage sector is highly competitive, and include international, national,

regional and local producers and distributors. Competitive factors in the beverage industry include price and promotional activity, advertising

and marketing programs, point-of-sale merchandising, retail space management, customer service, product differentiation, packaging innovations

and distribution methods.

Manufacturing and Co-packing

Although we are responsible for manufacturing tequila

products, we do not directly manufacture these products, but instead outsource such manufacturing to third party bottlers and contract

packers and distillers.

Chispo products are manufactured in Mexico, under

contract manufacturing arrangements. These co-packaging arrangements are terminable upon request and do not obligate us to produce any

minimum quantities of products within specified periods.

Historically our business strategy has entailed purchasing

concentrates, flavors, dietary ingredients, cans, bottles, caps, labels, and other components and ingredients for our beverage products

from our suppliers, which are delivered to our manufacturing operations and various third-party bottlers and co-packers. In some cases,

certain common supplies may be purchased by our various third-party bottlers and co-packers. Depending on the product, the third-party

bottlers or packers add other ingredients for the manufacture and packaging of the finished products into our approved containers in accordance

with our formulas.

Distribution

For our beverage-alcohol products, we operated within

what is referred to as a “Three Tier Distribution System” where manufacturers are not permitted to sell directly to retailers,

but instead contract for local and regional distribution with independent distributors. These distributors typically have geographic rights

to distribute major beverage brands and call on every store in a given area such as major cities or regions. Our President and CMO has

extensive experience working within this channel and believes that we may be successful in building a strong network of these distributors.

In addition to working with these independent distributors,

we also previously established distribution arrangements with national retail accounts.

Employees

We have one full-time employee our President who has

extensive experience in the beverage business, one part-time employee, our Chief Financial Officer and a part-time accounting consultant.

All of our employees and our consultant work remotely.

Listing on the NYSE American

Our Common Stock is listed on the NYSE American exchange

under the ticker symbol “SBEV”.

Corporate Information

We are a Nevada corporation. Our website address is www.splashbeveragegroup.com.

Our website is not incorporated into this Report.

4

Available Information

We file annual, quarterly, and current reports, proxy

statements and other information with the U.S. Securities Exchange Commission (the “SEC”). These filings are available to

the public through the SEC’s website at http://www.sec.gov. All statements made in any of our securities filings, including all

forward-looking statements or information, are made as of the date of the document in which the statement is included unless otherwise

specified, and we do not assume or undertake any obligation to update any of those statements or documents unless we are required to do

so by law.

Item 1A. Risk Factors.

You should carefully consider the risks described

below as well as other information provided to you in this document, including information in the section of this document entitled “Cautionary

Note Concerning Forward Looking Statements.” If any of the following risks actually occur, the Company’s business, financial

condition or results of operations could be materially adversely affected, the value of the Company’s Common Stock could decline,

and you may lose all or part of your investment.

RISKS RELATED TO OUR BUSINESS

Risks Related to our Financial Condition

Our auditors have included an explanatory paragraph

in their opinion regarding our ability to continue as a going concern. If we are unable to continue as a going concern, our stockholders

will lose all or some of their investments.

Rose, Snyder & Jacobs LLP, our independent registered

public accounting firm for the fiscal year ended December 31, 2025, has included an explanatory paragraph in their opinion that accompanies

our audited consolidated financial statements as of and for the year ended December 31, 2025, indicating that our current liquidity position

raises substantial doubt about our ability to continue as a going concern. If we are unable to improve our liquidity position, we may

not be able to continue as a going concern. This has continued as of the date of this Report.

We have sustained recurring losses and we have had

working capital and stockholders’ equity deficits. These prior losses and expected future losses have had, and will continue to

have, an adverse effect on our financial condition. In addition, continued operations and our ability to continue as a going concern may

be dependent on our ability to obtain additional financing in the near future and thereafter, and there are no assurances that such financing

will be available to us at all or will be available in sufficient amounts or on reasonable terms. Our financial statements do not include

any adjustments that may result from the outcome of this uncertainty. If we are unable to generate additional funds in the future through

sales of our products, financing or from other sources or transactions, we will exhaust our resources and will be unable to continue operations.

These conditions raise substantial doubt about the Company’s ability to continue as a going concern for the next 12 months.

In order to continue and fund its operations, the

Company will be required to obtain additional resources through sales and issuances of equity to successfully execute its business plans

and keep the Common Stock listed on the NYSE American. No assurances can be given the Company will be successful in raising additional

capital, if needed, or on acceptable terms. Sales of Common Stock or Common Stock equivalents would have the effect of diluting existing

stockholders. If we are unable to raise the necessary capital on favorable terms, within the timeframes needed or at all, we could be

forced to cease operations, and you could lose all or some of your investment.

Because we lack the required $6 million of minimum

stockholders’ equity currently as well at December 31, 2025, our Common Stock may be delisted by the NYSE American.

On April 7, 2025, the NYSE American notified the Company

that as a result of its failure to comply with the applicable continued listing rules including maintaining the required minimum stockholders’

equity, it determined to commence proceedings to delist the Company’s Common Stock from the exchange. The Company appealed the determination.

5

On June 25, 2025, we acquired our Water Assets by

issuing the Seller shares of our Series C Convertible Preferred Stock. The Series C contains a stated value of $20 million. Under Generally

Accepted Accounting Principles, we accounted for this issuance by including $20 million of non-current assets on our balance sheet. On

April 14, 2026, the Company rescinded the transaction and canceled the Series C in accordance with the provisions of the Asset Purchase

Agreement, effective December 31, 2025. If we can complete the acquisition of Medterra, we expect we will have stockholders’ equity

substantially above the $6 million minimum requirement. We cannot assure you that we will complete the acquisition of Medterra or that

the NYSE American will permit our Common Stock to remain listed both prior to the planned closing and after the closing of the Medterra

acquisition.

Because we lack the capital to acquire inventory

and market our products, we have generated no revenue in 2025 after the three months ended March 31, 2025, making our ability to remain

in operation more difficult, and there are substantial doubts as to our ability to continue as a going concern.

As reflected in this the consolidated financial statements

contained in this Report, we had only $442,732 in net revenues for the year ended December 31, 2025. In fact, we

did not generate any revenue in fiscal year 2025 after the three months ended March of 2025 due to a lack of operating capital

which has hindered the Company’s ability to generate sales since that time. In order to generate material revenue, we estimate requiring

at least $2,000,000 of working capital in order to acquire inventory and re-commence minimal operations. This does not include our plans

for the Chispo tequila business which will require substantial additional capital. Specifically, management estimates needing approximately

$500,000 to achieve its full year goals. In addition, we need approximately $3 million in working capital to grow our business, pay our

current management, including benefits, an accounting consultant and the public company costs we are required to pay.

We have also entered into the Letter of Intent with Medterra contemplating

a potential business combination with that entity. Assuming we enter into a definitive Agreement with Medterra and close the acquisition,

we expect we will need approximately $10,000,000 to pay its indebtedness and the income taxes of Medterra’s investors and are working

with capital partners and investors to attempt to raise an additional $25,000,000 at or subsequent to the closing of the proposed transaction

to expand Medterra’s existing operations and sales inclusive of their participation in the recently launched federal CMS pilot program,

additional working capital, and reserves. See “Risk Factors - Risks Related to. Our Business.”

Our lack of cash resources has prevented us from carrying

on our commercialization activities. In addition, our lack of working capital has prevented us from marketing our products. Further, even

if we can access the necessary capital, the Company must determine whether and what extent to invest such capital into various aspects

of our business, including recommencing sales of beverage products, and we may be unsuccessful in developing and executing a business

plan in this regard. Unless we raise enough money to not only pay our ongoing general and administrative expenses but also market our

products and purchase inventory, we will not be able to remain operational.

We have experienced recurring losses from operations

and negative cash flows from operating activities and anticipate that we will continue to incur significant operating losses before reaching

profitability.

We have experienced recurring losses from operations and negative cash flows

from operating activities. We expect to continue to incur significant expenses related to our ongoing operations and generate operating

losses for the foreseeable future. The size of our losses will depend, in part, on the rate of future expenditures, our ability to execute

our business plan and our ability to generate revenues. We incurred a net loss from continuing operations of approximately $25.2

million including $14.2 million of non-cash items for the year ended December 31, 2025.

We may encounter unforeseen expenses, difficulties,

complications, delays, and other unknown factors that may adversely affect our financial condition. Our prior losses and expected future

losses have had, and will continue to have, an adverse effect on our financial condition. If our products do not achieve sufficient market

acceptance and we do not generate significant revenues, we may never become profitable. Even if we achieve profitability in the future,

for which we can provide no assurance, we may not be able to sustain profitability in subsequent periods. Our failure to become and remain

profitable would decrease the value of our company and could impair our ability to raise capital, expand our business, diversify our product

offerings or continue our operations. A decline in the value of our Company could cause you to lose all or part of your investment.

6

We may become subject to litigation in connection

with our cancellation of the Series C that we had previously issued under the Asset Purchase Agreement related to certain water assets.

Following the cancellation of

the Series C that we had previously issued to the Seller under the Asset Purchase Agreement related to certain water assets located in

Costa Rica, the Seller may determine to sue us challenging our position with respect to such cancellation. Specifically, Section 1.04

of the Asset Purchase Agreement required the Seller to deliver the water assets by December 31, 2025 or pay the Company $20 million

in cash, and further stated that failure to deliver either the water assets or the $20 million by December 31, 2025 rendered the

Series C to be “null, void, and of no further force or effect.” As a result, the Company cancelled the Series C effective

December 31, 2025. While the Company believes that it has adequate evidence demonstrating that the Seller failed to comply with either

requirement, the Seller may nonetheless seek to sue the Company claiming that the Company was not entitled to cancel the Series C. Any

resulting litigation which may arise from the foregoing could require us to incur significant costs and expenses, subject us to uncertainty

with respect to our outstanding capital stock and any potential future transactions (including the potential business combination with

Medterra), and divert our limited personnel and resources away from operational matters and strategic initiatives.

Risks Related to our

Business

If we are unable to enter

into a definitive agreement and close an acquisition of Medterra following our entry into a non-binding Letter of Intent on March 4, 2026

as described elsewhere in this Report, the Company and its stockholders will not receive the anticipated and intended benefits of such

acquisition, and the Company would be forced to pursue alternative acquisitions or strategic transactions.

As disclosed elsewhere in this Report, we recently

entered into a Letter of Intent with Medterra, a leading manufacturer and multi-brand operator of cannabinoid wellness products. Pursuant

to the Letter, the parties agreed in principal on the terms of a potential business combination between Medterra and the Company, subject

to due diligence and execution of a definitive written agreement and other applicable agreements, receipt of the 2025, audited financial

statements of Medterra and customary closing conditions. In addition, the Company needs approximately $10.4 million of cash to close the

transaction. The proposed terms for the transaction represent an enterprise value of Medterra of $37.6 million or the issuance of approximately

54,400,000 shares of Common Stock, which assumes repayment of its outstanding debt. This would represent substantial dilution to the Company’s

existing stockholders.

While the closing of the

acquisition would result in us becoming the parent holding company of a leading manufacturer and seller of cannabinoid products, the closing

may not occur, including due to regulatory challenges arising from cannabis laws and the NYSE American requirements, our ability to raise

the necessary cash and negotiate the definitive agreement, due diligence, the appearance of a competitive bid from another prospective

purchaser, or the seller’s inability to maintain its operations for a sufficient time to allow the transaction to close, and other

events and requirements that may not occur on favorable terms or at all and subject any potential transaction to substantial uncertainty.

The Letter is non-exclusive and does not provide us with any recourse if Medterra were to decline to move forward with a transaction with

us. The Letter also envisions us being required to raise a substantial amount of additional capital shortly following the closing of the

business combination, which would further dilute our existing stockholders and could subject us to onerous terms that harm our ability

to operate or pursue strategic transactions and alternatives. Even if we do acquire Medterra and raise the necessary capital to fund post-transaction

operations in the future, there can be no assurance that such a development will yield the intended or expected benefits, result in sustained

increases in prices and or volume of trading in our Common Stock, or otherwise create a meaningful return on investment or value to our

stockholders.

Further, if we fail to enter

into a definitive written agreement or a business combination does not close, all of the time and capital resources expended by the Company

in such pursuit of such a transaction may be lost and unrecoverable by the Company or its stockholders. Unanticipated issues which may

be beyond our control or that of the seller may arise that force us to suspend our pursuit of the target, including those referred to

elsewhere herein. Such risks are inherent in any search for a new business and investors should be aware of them before investing in an

enterprise such as ours.

Our strategic initiatives

including acquisitions and divestitures may not be successful and may divert our management’s attention away from operations, and

could create general customer uncertainty.

We have begun to explore

strategic alternatives to our beverage business. Our growth strategy is based in part on growth through strategic initiatives including

both acquisitions and divestitures of brands and assets, which poses a number of risks. We may not be successful in identifying appropriate

acquisition candidates, achieving targeted values as part of a disposition, consummating an acquisition or divestiture on satisfactory

terms, integrating any newly acquired or expanded business with our current operations, or separating a divested business or commingled

operation effectively. We may issue additional equity, incur long-term or short-term indebtedness, spend cash or use a combination of

these for all or part of the consideration paid in future acquisitions or expansion of our operations, which may not be available to us

on terms we find advantageous or acceptable, if at all. In addition, subject to any requirements in the agreements governing our outstanding

indebtedness, we may have significant discretion in how we employ the consideration received in a divestiture and our management may not

apply such consideration in a way that is ultimately accretive to our business.

7

The execution of our strategic

initiatives will likely entail incurring goodwill assets or repositioning or similar actions that in turn require us to record impairments,

restructuring and other charges. Any such charges would result in additional expense. We cannot guarantee that any future business acquisitions

or divestitures will be pursued or that any acquisitions or divestitures that are pursued will be consummated.

Additionally, any acquisition

or disposition (including the successful integration and separation of operations, products and personnel) may place a significant burden

on our management and other internal resources. The diversion of management’s attention, and any difficulties encountered in such

a process, could harm our business, financial condition, and operating results.

If we fail to successfully integrate acquired assets

or businesses, or if integrated, failure to further the Company’s business strategy, may result in the Company’s inability

to realize any benefit from such acquisition or other adverse consequences.

As disclosed above under “Business-Letter of Intent”, we are in

discussions concerning a potential acquisition of Medterra contemplated by the Letter of Intent with that entity. Unidentified liabilities

or other issues may arise with respect to the businesses and assets we have acquired or may in the future acquire, which could expose

us to litigation, unexpected costs, regulatory actions and other negative events that could materially harm our business and financial

condition. Further, we intend for = any such acquisitions to be a critical part of our business plan moving forward, subject to accessing

the necessary capital, and such acquisitions may not yield the benefits expected or desired for our business.

In addition, even if we can access the necessary capital,

we may face challenges in integrating and utilizing any acquired business or assets, particularly given any such undertaking will require

the investment of resources to monetize and integrate into our other operations. Even if we can access the necessary capital to further

these efforts we may be unable to effectively manage these efforts without incurring extensive additional costs or at all. This would

put a further strain on our already limited personnel and resources. Further, the long-term commercial success of any such undertaking

will depend on our ability to timely and in a cost-effective manner pursue and develop an infrastructure and network to obtain and distribute

products in high quantities and in compliance with applicable regulatory and commercial requirements. If we are unsuccessful in navigating

these challenges with respect to any acquired business or assets, it could fail to result in benefits to our Company, and we could be

materially adversely affected by any of the foregoing events.

In general, the consummation and integration of any

acquired business or assets into the Company may be complex and time-consuming and, if such businesses and assets are not successfully

integrated, the Company may not achieve the anticipated benefits, cost-savings or growth opportunities. Furthermore, these acquisitions

and other arrangements, even if successfully integrated, may fail to further the Company’s business strategy as anticipated, expose

the Company to increased competition or other challenges with respect to the Company’s products or geographic markets, and expose

the Company to additional liabilities associated with an acquired business, technology or other asset or arrangement. There are no guarantees

that the Company will successfully consummate such acquisitions, and even if the Company consummates such acquisitions, the procurement

of applications for licenses required to sell or distribute related products may never result in the grant of a license by any state or

local governmental or regulatory agency and the transfer of any rights to licenses may never be approved by the applicable federal, state

and/or local governmental or regulatory agency.

Demand for our products

may be adversely affected by changes in consumer preferences or any inability on our part to innovate, market or distribute our products

effectively, and any significant reduction in demand could adversely affect our business, financial condition or results of operations.

We aim to sell beverages comprised of a number of

unique brands with reputations and consumer imagery that have been built over time. Our investments in marketing as well as our strong

commitment to product quality are intended to have a favorable impact on brand image and consumer preferences. If we do not adequately

anticipate and react to changing demographics, consumer and economic trends, health concerns and product preferences, our financial results

could be adversely affected.

8

Additionally, failure to introduce new brands, products

or product extensions into the marketplace as current ones mature and to meet the changing preferences of consumers could prevent us from

gaining market share and achieving long-term profitability. Product lifecycles can vary, and consumer preferences and loyalties change

over time. Although we try to anticipate these shifts and innovate new products to introduce to our consumers, we may not succeed. Consumer

preferences also are affected by factors other than taste, such as health and nutrition considerations and obesity concerns, shifting

consumer needs, changes in consumer lifestyles, increased consumer information and competitive product and pricing pressures. Sales of

our products may be adversely affected by negative publicity associated with these issues. If we do not adequately anticipate or adjust

to respond to these and other changes in consumer preferences, we may not be able to maintain and grow our brand images, and our sales

may be adversely affected.

Volatility in the price or availability of the

inputs we depend on, including raw materials, packaging, energy and labor, could adversely impact our financial results.

The principal raw materials we use include glass bottles,

aluminum cans, polyethylene terephthalate, fiber-board, labels and cardboard cartons, flavorings and sweeteners. These component and ingredient

costs are subject to fluctuation and environmental regulation. If there were to be substantial increases in the prices of these products,

to the extent that they cannot be recouped through increases in the prices of finished beverage products, it would increase our operating

costs. If our supply of these raw materials is impaired or if prices increase significantly due to tariffs or any other reason, it could

affect the affordability of our products and reduce revenues.

If we are unable to secure sufficient ingredients

or raw materials including glass, sugar, and other key supplies at acceptable prices, within a reasonable timeframe, at the locations

needed or in general, we might not be able to satisfy demand on a short-term basis.

International trade developments, including tariffs

and geopolitical conflicts, could adversely impact our business.

International trade developments, including heightened

tariffs imposed by the United States under the Trump Administration on goods imported from various countries, tariffs imposed by foreign

countries in retaliation, and litigation and uncertainties surrounding these developments, could adversely impact our business. Further,

geopolitical conflicts such as the conflict with Iran and its proxies have had and are expected to continue to have an adverse impact

on supply chains and the costs of purchasing and transporting goods. We and third parties on which we depend source various supplies used

in our products from foreign countries, and tariffs and other international trade developments could therefore result in inflationary

pressures that directly impact our costs for manufacturing and marketing products. These developments could also adversely impact global

supply chains which could further increase costs for us and/or delay delivery of key inventories and supplies.

Significant new or increased tariffs, import and excise

duties, or other taxes on or impacting beverage products, including raw and packaging materials, such as on imports from Mexico and exports

to countries in which we plan to sell our products such as the United Arab Emirates from which we source many of our supplies for our

products, and any additional retaliatory tariffs imposed by those governments on products imported into the U.S., could have a material

adverse effect on our business, liquidity, financial condition, and results of operations. These developments continue to pose a significant

risk to our business as well as the U.S. and global economies, including by shifting consumer behaviors, inhibiting sales, increasing

costs, causing further economic and supply chain disruptions and inflationary pressures, and reducing economic activity. For example,

if the costs of our products increase, we and our collaborators may be forced to increase the prices at which such products are sold,

which could in turn reduce demand for and sales of those products, thereby negatively impacting our operating results. Alternatively,

the heightened production costs would also have a negative impact on operating results even absent a decline in sales. Further, increases

in the cost of oil and other resources used in the production and transportation of products could have a material adverse effect on the

acquisition and use of such resources and gross margins.

9

The extent and duration of the tariffs and the resulting

impact on our business and general economic conditions are uncertain and depend on various factors, including negotiations between the

United States and affected countries, the outcome of the United States tariff litigation, the responses of other countries or regions,

exemptions or exclusions that may be granted, availability and cost of alternative sources of supply, and demand for our products in affected

markets. To the extent we need to locate new sources of raw materials and products as a result of tariffs, we may be unable to locate

alternative sources on favorable terms or in the timeframes needed, and actions we may take to adapt to new tariffs or trade restrictions

may force us to modify our operations or forgo business opportunities. Likewise, tariffs and import and export regulations could also

limit the availability of our products, prompt consumers to seek alternative products, and provide an opportunity for competitors not

subject to such tariffs to more effectively compete with us in markets where we conduct our business.

Our business, operations, financial position and

timelines, could be materially adversely affected by government action and geopolitical conflicts.

Following President Trump’s inauguration in

January 2025, certain trends and events have unfolded and continue to evolve and develop which are affecting and have the potential to

further affect the global and United States capital markets and economies, including the inflation caused by the conflict with Iran, the

continued high central bank interest rates, the imposition and threat of tariffs as well as subsequent developments and uncertainties

surrounding tariffs, trade wars among nations and ongoing wars and geopolitical conflicts, and uncertain capital markets with significant

volatility and declines in leading market indexes thus far 2026. The duration and scope of these events and their impact are at best uncertain,

and their continuation may result in negative consequences on the U.S. or global economies.

The impositions of tariffs by the U.S. and any retaliatory

actions by foreign countries, as well as refunds on tariffs following the U.S. Supreme Court’s ruling to strike down certain tariffs,

could contribute to higher inflation and reduced economic activity for a prolonged period of time, thereby delaying any rate reductions

or potentially resulting in rate increases in the future, as well as reduced demand for mortgages. Similarly, the wars in the Middle East

and the Ukraine could also contribute to increased and prolonged inflation including by increasing the price of oil and causing adverse

impacts on supply chains. These uncertainties and developments could result in supply chain issues, higher prices for goods and services

or other adverse consequences on us and our vendors. In addition, these events come with an increased probability for an economic downturn

or recession by making it more difficult for businesses to borrow money and individuals to maintain employment.

These developments follow the increase in interest

rates that began in 2022 as the Federal Reserve in U.S. and central banks in other jurisdictions have sought to combat inflation. While

in the U.S. inflation has declined, the conflict with Iran seems likely to having another inflationary impact. Further many economists

view additional increases in inflation as a likely or possible consequence of these developments. Uncertainty surrounding rising or elevated

prices and concerning the state and prospects for the U.S. and global economies and capital markets in the near term remains and has amplified

due to the factors described above. If inflation does not fall low enough and/or the Federal Reserve declines to reduce interest rates

in the near term, or tariffs and related developments adversely impact the economy, the result could be tipping the U.S. economy into

a recession. In the wake of these events, the U.S. and global capital markets have demonstrated substantial volatility in the first quarter

of 2026, as many investors consider economic outlooks to be uncertain and consider the risk of a recession and a decline in the marketplace

to be increasingly probable or imminent. Ultimately the economy may turn into a recession with uncertain and potentially severe impacts

upon the public capital markets and us. Among the potential consequences could be a substantial decline in stock prices including ours,

a reduction in demand for securities of public companies (which may be more prevalent for smaller companies such as us) and more difficulty

for us to raise capital we need and accessing capital on favorable terms or at all as a result.

As our ability to continue to operate will be dependent

on raising capital, any adverse impact to markets as a result of these developments, including due to increased market volatility, decreased

availability in third-party financing and/or a deterioration in the terms on which it is available (if at all), could negatively impact

our business, results of operations, cash flows, financial condition, and/or prospects. The extent of any potential impact is not yet

determinable, however.

10

We compete in an industry that is brand-conscious,

so brand name recognition and acceptance of our products are critical to our success.

Our business is dependent upon awareness and market

acceptance of our products and brands by our target markets. In addition, our business depends on acceptance by our independent distributors

and retailers of our brands as beverage brands that have the potential to provide incremental sales growth. If we are not successful in

the revitalization and growth of our brand and product offerings, or in maintaining and expanding upon the brands we offer, we may not

achieve and maintain satisfactory levels of acceptance by independent distributors and retail consumers. Any failure of our brands to

maintain or increase acceptance or market penetration would likely have a material adverse effect on our revenues and financial results.

Our brands and brand images are keys to our business

and any inability to maintain a positive brand image could have a material adverse effect on our results of operations.

Our success depends on our ability to develop brand

images for our existing products and effectively build up brand images for new products and brand extensions. We cannot predict whether

our advertising, marketing and promotional programs will have the desired impact on our products’ branding and on consumer preferences.

In addition, negative public relations and product quality issues, whether real or imagined, could tarnish our reputation and images of

the affected brands and could cause consumers to choose other products. Our brand images can also be adversely affected by unfavorable

reports, studies and articles, litigation, or regulatory or other governmental action, whether involving our products or those of our

competitors.

Competition from traditional

and large, well-financed non-alcoholic and alcoholic beverage manufacturers may adversely affect our distribution relationships and may

hinder development of our existing markets, as well as prevent us from expanding our markets.

The beverage industry is highly competitive. We compete

with other beverage companies not only for consumer acceptance but also for shelf space in retail outlets and for marketing focus by distributors,

all of whom also distribute other beverage brands. Our products will compete with a broad range non-alcoholic and alcoholic beverages,

many of which are marketed by companies with substantially greater financial and marketing resources than ours. Management believes that

some of these competitors are placing severe pressure on independent distributors not to carry competitive brands offered by smaller enterprises

such as ours. We will also compete with regional beverage producers and “private label” brands.

Increased competitor consolidations, market-place

competition, particularly among branded beverage products, and competitive product and pricing pressures could impact our earnings, market

share and volume growth. If, due to such pressure or other competitive threats, we are unable to sufficiently maintain or develop our

distribution channels, we may be unable to achieve our current revenue and financial targets. Competition, particularly from companies

with greater financial and marketing resources than ours, could have a material adverse effect on our existing markets, as well as on

our ability to expand the market for our products.

Our reliance on distributors, retailers and brokers

could affect our ability to efficiently and profitably distribute and market our products, maintain our existing markets and expand our

business into other geographic markets.

Our ability to maintain and expand our existing markets

for our products, and to establish markets in new geographic distribution areas, is dependent on our ability to establish and maintain

successful relationships with reliable distributors, retailers and brokers strategically positioned to serve those areas. All of the distributors,

retailers and brokers we have used in the past sell and distribute competing products, including non-alcoholic and alcoholic beverages,

and our products may represent a small portion of their businesses. The success of this network will depend on the performance of the

distributors, retailers and brokers of this network. There is a risk that the mentioned entities may not adequately perform their functions

within the network by, without limitation, failing to distribute to sufficient retailers or positioning our products in localities that

may not be receptive to our product. Further, these third parties could reduce or terminate their relationship with us for any reason

without liability to us. Our ability to incentivize and motivate distributors to manage and sell our products is affected by competition

from other beverage companies, some of which may have greater resources than we do. To the extent that our distributors, retailers and

brokers are distracted from selling our products or do not employ sufficient efforts in managing and selling our products, including re-stocking

the retail shelves with our products, our results of operations could be adversely affected. Furthermore, such third-parties’ financial

position or market share may deteriorate, which could adversely affect our distribution, marketing and sales activities.

11

Our ability to establish and expand our distribution

network and attract additional distributors, retailers and brokers will depend on a number of factors, some of which are outside our control.

Some of these factors include:

We may not be able to successfully manage all or any

of these factors in any of our current or prospective geographic areas of distribution. Our inability to achieve success with regards

to any of these factors in a geographic distribution area will have a material adverse effect on our relationships in that particular

geographic area, thus limiting our ability to maintain or expand our market, which will likely adversely affect our revenues and financial

results.

These third-party service providers and business partners

are also subject to similar risks as we are relating to cybersecurity, privacy violations, business interruption, and systems and employee

failures, and are subject to legal, regulatory and market risks of their own. Our third-party service providers and business partners

may not fulfill their respective commitments and responsibilities in a timely manner and in accordance with the agreed-upon terms. In

addition, while we have procedures in place for selecting and managing our relationships with third-party service providers and other

business partners, we do not have control over their business operations or governance and compliance systems, practices and procedures,

which increases our financial, legal, reputational and operational risk. If we are unable to effectively manage our third-party relationships,

or for any reason our third-party service providers or business partners fail to satisfactorily fulfill their commitments and responsibilities,

our financial results could suffer.

It is difficult to predict the timing and amount

of our sales because our distributors are not required to place minimum orders with us.

Once we re-commence sales, we plan to use independent

distributors who will not be required to place minimum monthly or annual orders for our products. In order to reduce their inventory costs,

independent distributors typically order products from us on a “just in time” basis in quantities and at such times based

on the demand for the products in a particular distribution area. Accordingly, we cannot predict the timing or quantity of purchases by

any of our independent distributors or whether any of our distributors will purchase products from us in the same frequencies and volumes

as they may have done in the past. Additionally, our larger distributors and national partners may make orders that are larger than we

have historically been required to fill. Shortages in inventory levels, supply of raw materials or other key supplies could negatively

Source: SEC EDGAR (public domain) · 10-K for the period ended 2025-12-31, filed 2026-04-15 · accession 0001731122-26-000577

Filing HTML rendered to line-structured narrative text by the shipped reducer (datafeeds.edgar_fulltext.visible_text, keep_table_headers=True): scripts and inline-XBRL headers are dropped, and table content is reduced to its short label cells — numeric table data is not rendered and is therefore not counted. The same rendering is used for every year, so a year-over-year comparison is like for like.

The text is our rendering of the filing, not a facsimile: original pagination, typography and tables are not reproduced, and the numbers live in the financial statements (FA).

The outline locates item HEADINGS in this document. Only Items 1A and 7 have certified boundaries elsewhere in the terminal (the redline and the narrative-overlap number); every span here runs from one heading found to the next heading found.

How the outline was chosen. It is the longest chain of item headings that runs forward through both the document and the standard item order: 17 headings are on that chain and 17 further heading-shaped lines are not — the table-of-contents echo of every item, cross-references and exhibit-list mentions. Each entry's length is measured from its heading to the next heading on the chain.